SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2021-10-05 15:53
Tx date 2021-10-01
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+8,539 vol
59,615
Filed 2021-10-05 15:52
Tx date 2021-09-30
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV, L.P. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$175,290
+54,438 vol
$3.22 each
128,607
Filed 2021-10-05 15:51
Tx date 2021-09-30
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV (International) L.P. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$4,710
+1,463 vol
$3.22 each
3,456
Filed 2021-09-21 16:17
Tx date 2021-09-16
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+26,318 vol
36,398
Filed 2021-09-21 16:16
Tx date 2021-09-16
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+26,318 vol
Filed 2021-09-21 09:00
Tx date 2021-09-16
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+26,318 vol
36,398
Filed 2021-09-21 09:00
Tx date 2021-09-16
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+26,318 vol
Filed 2021-09-21 08:57
Tx date 2021-09-16
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+13,159 vol
51,076
Filed 2021-07-07 08:29
Tx date 2021-07-01
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
$25,176
+3,536 vol
$7.12 each
37,917
Filed 2021-04-27 16:26
Tx date 2021-04-22
$EDSA
Edesa Biotech, Inc.
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options Stock Options
50 - Grant of options

+20,000 vol
51,389
Filed 2021-04-05 10:55
Tx date 2021-04-01
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+3,195 vol
34,381
Filed 2021-02-25 11:51
Tx date 2021-02-23
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III (International), L.P. (Indirect Ownership)
Common Shares
15 - Acquisition or disposition under a prospectus
$65,018
+9,661 vol
$6.73 each
9,661
Filed 2021-02-25 11:51
Tx date 2018-10-16
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III (International), L.P. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-25 11:50
Tx date 2021-02-23
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III (International), L.P. (Indirect Ownership)
Warrants
15 - Acquisition or disposition under a prospectus

+4,830 vol
4,830
Filed 2021-02-25 11:49
Tx date 2018-10-16
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III (International), L.P. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-25 11:49
Tx date 2021-02-23
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III, L.P. (Indirect Ownership)
Warrants
15 - Acquisition or disposition under a prospectus

+145,170 vol
145,170
Filed 2021-02-25 11:47
Tx date 2018-10-16
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III, L.P. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-25 11:47
Tx date 2021-02-23
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III, L.P. (Indirect Ownership)
Common Shares
15 - Acquisition or disposition under a prospectus
$1,953,981
+290,339 vol
$6.73 each
290,339
Filed 2021-02-25 11:46
Tx date 2018-10-16
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III, L.P. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-23 12:09
Tx date 2020-12-19
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+10,080 vol
10,080
Filed 2020-12-23 12:08
Tx date 2018-10-16
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-23 12:08
Tx date 2020-12-19
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+5,040 vol
31,186
Filed 2020-10-16 20:48
Tx date 2020-10-13
$EDSA
Edesa Biotech, Inc.
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options Stock Options
50 - Grant of options

+20,000 vol
31,389
Filed 2020-08-26 15:30
Tx date 2020-08-24
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+13,924 vol
26,146
Filed 2020-08-26 15:29
Tx date 2020-08-24
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+13,924 vol
Filed 2020-08-26 11:45
Tx date 2020-08-24
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+13,924 vol
Filed 2020-08-26 11:45
Tx date 2020-08-24
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+13,924 vol
26,146
Filed 2020-04-04 21:20
Tx date 2020-03-31
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV, L.P. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$175,291
+74,169 vol
$2.36 each
74,169
Filed 2020-04-04 21:19
Tx date 2018-10-16
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV, L.P. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-04-04 21:19
Tx date 2020-03-31
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV (International) L.P. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$4,710
+1,993 vol
$2.36 each
1,993
Filed 2020-04-04 21:17
Tx date 2018-10-16
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV (International) L.P. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-02-17 18:21
Tx date 2020-02-12
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.)
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options Stock Options
50 - Grant of options

+11,389 vol
11,389
Filed 2020-02-17 18:18
Tx date 2019-06-07
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.)
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options Stock Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-01-13 23:01
Tx date 2020-01-08
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.)
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately

+5,952 vol
5,952
Filed 2020-01-13 23:00
Tx date 2019-06-07
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.)
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
Warrants Class B Purchase Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-01-13 22:59
Tx date 2020-01-08
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.)
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately

+64,362 vol
64,362
Filed 2020-01-13 22:58
Tx date 2019-06-07
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.)
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
Warrants Class B Purchase Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-01-13 22:57
Tx date 2020-01-08
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.)
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately

+96,542 vol
96,542
Filed 2020-01-13 22:56
Tx date 2019-06-07
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.)
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
Warrants Class A Purchase Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-01-13 22:55
Tx date 2020-01-08
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.)
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately

+8,928 vol
8,928
Filed 2020-01-13 22:48
Tx date 2020-01-08
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.)
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately

+96,542 vol
Filed 2020-01-13 22:47
Tx date 2019-06-07
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.)
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
Warrants Class A Purchase Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-01-13 22:46
Tx date 2020-01-08
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.)
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately
$38,089
+11,903 vol
$3.20 each
169,502
Filed 2020-01-13 22:45
Tx date 2020-01-08
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.)
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately
$411,910
+128,722 vol
$3.20 each
1,833,066
Filed 2019-07-31 14:04
Tx date 2019-07-26
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.)
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately

+8,600 vol
157,599
Filed 2019-07-31 14:04
Tx date 2019-07-26
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.)
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately

+93,006 vol
1,704,344
Filed 2019-06-20 17:36
Tx date 2019-06-07
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.)
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
Common Shares
37 - Stock split or consolidation

-744,992 vol
148,999
Filed 2019-06-20 17:32
Tx date 2019-06-07
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.)
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
Common Shares
37 - Stock split or consolidation

-8,056,689 vol
1,611,338
Filed 2019-06-20 17:31
Tx date 2019-06-07
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.)
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II (International), L.P. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
893,991
Filed 2019-06-20 17:30
Tx date 2019-06-07
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.)
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Lumira Capital II, L.P. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
9,668,027
Filed 2019-03-05
Tx date 2018-12-19
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+12,222 vol
12,222
Filed 2019-03-05
Tx date 2018-12-19
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+12,222 vol
Filed 2018-12-21
Tx date 2018-12-19
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+12,222 vol
12,222
Filed 2018-12-21
Tx date 2018-10-16
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2018-10-22
Tx date 2018-10-16
$PDP
Pediapharm Inc.
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV (International) L.P. (Control or Direction)
Convertible Debentures 6% Unsecured
00 - Opening Balance-Initial SEDI Report
$157,000
Filed 2018-10-22
Tx date 2018-10-16
$PDP
Pediapharm Inc.
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV, L.P. (Control or Direction)
Convertible Debentures 6% Unsecured
00 - Opening Balance-Initial SEDI Report
$5,843,000